Business Description
PharmaCielo Ltd
NAICS : 325411
SIC : 3741
ISIN : CA00035L1022
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.11 | |||||
Debt-to-Equity | 6.03 | |||||
Debt-to-EBITDA | -1.87 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -10.72 | |||||
Beneish M-Score | 7.03 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 63.6 | |||||
3-Year EBITDA Growth Rate | 39.7 | |||||
3-Year EPS without NRI Growth Rate | 36.7 | |||||
3-Year FCF Growth Rate | 43.3 | |||||
3-Year Book Growth Rate | -55.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 17.8 | |||||
9-Day RSI | 29.92 | |||||
14-Day RSI | 37.05 | |||||
6-1 Month Momentum % | 2.44 | |||||
12-1 Month Momentum % | -2.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.45 | |||||
Quick Ratio | 0.17 | |||||
Days Inventory | 218.84 | |||||
Days Sales Outstanding | 30.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.1 | |||||
Shareholder Yield % | -17.08 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -34.01 | |||||
Operating Margin % | -357.45 | |||||
Net Margin % | -456.07 | |||||
FCF Margin % | -184.49 | |||||
ROE % | -243.88 | |||||
ROA % | -49.32 | |||||
ROIC % | -43.35 | |||||
ROC (Joel Greenblatt) % | -47.69 | |||||
ROCE % | -56.3 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10 | |||||
PB Ratio | 10.59 | |||||
Price-to-Tangible-Book | 7.5 | |||||
EV-to-EBIT | -4.09 | |||||
EV-to-EBITDA | -4.72 | |||||
EV-to-Revenue | 15.07 | |||||
EV-to-FCF | -9.15 | |||||
Earnings Yield (Greenblatt) % | -24.46 | |||||
FCF Yield % | -20.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PharmaCielo Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 2.811 | ||
EPS (TTM) (C$) | -0.08 | ||
Beta | 0.71 | ||
Volatility % | 49.67 | ||
14-Day RSI | 37.05 | ||
14-Day ATR (C$) | 0.021225 | ||
20-Day SMA (C$) | 0.20875 | ||
12-1 Month Momentum % | -2.33 | ||
52-Week Range (C$) | 0.105 - 0.29 | ||
Shares Outstanding (Mil) | 170.38 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PharmaCielo Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PharmaCielo Ltd Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
PharmaCielo Ltd Frequently Asked Questions
What is PharmaCielo Ltd(TSXV:PCLO)'s stock price today?
When is next earnings date of PharmaCielo Ltd(TSXV:PCLO)?
Does PharmaCielo Ltd(TSXV:PCLO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |